Assessment of Psychological Comorbidities in Sickle Cell Disease Patients and Effect of Psychosocial Intervention

Advances in medical therapy have changed sickle cell disease (SCD), a life-threatening haemoglobinopathy, into a chronic illness of childhood extending into adulthood. Restrictions in daily life activities, behavioural inhibitions and associated social stigma have led to a significant psycho-socio-economic burden on patients and their families. This study was conducted to estimate the prevalence and severity of psychological comorbidities, namely stress, anxiety and depression among SCD patients and to assess the effect of psychosocial intervention through counselling, patient education and familial and social support. A total of 374 SCD patients aged >12 years, visiting the outpatient department (OPD), were recruited for the study and were assessed for psychological comorbidities using the validated Hindi version of the Depression Anxiety Stress Scale-42 (DASS-42). The questionnaires were administered by a trained psychologist. Out of these, 98 patients who consented for further participation were assessed for the effect of intervention in the form of verbal guidance sessions, self-help group sessions and provision of printed educational material. We observed that 53.74% of 374 patients were affected with at least one of the psychological comorbidities. Stress, anxiety and depression affected 27.54%, 49.20% and 32.89% of patients, respectively. The majority of affected patients had symptoms in the moderate to extremely severe range. We observed that the depression score increased by a factor of 0.419 and 0.558 for anxiety and stress, respectively. Interestingly, we observed a significantly higher prevalence of depression in females ( χ 2 (1) = 8.808, p = .0030). We also observed that prevalence and severity scores for stress, anxiety and depression among the patients showed a significant reduction in response to the psychosocial intervention. Our findings show a higher prevalence of psychological comorbidities in SCD patients and highlight the need for early identification and remediation of psychological comorbidities in SCD patients.

Authors

Institutions

Publication Details

Journal
Journal of Health Management
Published
2025-06-16
DOI
https://doi.org/10.1177/09720634251346314
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of Psychological Comorbidities in Sickle Cell Disease Patients and Effect of Psychosocial Intervention

Aditya Nath Jha, Radha Rani Sahoo, Gunjan Mishra, Hrishikesh Mishra et al.
Journal of Health Management
Hemoglobinopathies and Related Disorders
article

Assessment of Psychological Comorbidities in Sickle Cell Disease Patients and Effect of Psychosocial Intervention

Aditya Nath Jha, Radha Rani Sahoo, Gunjan Mishra, Hrishikesh Mishra, Akriti Gupta
article en

Abstract

Advances in medical therapy have changed sickle cell disease (SCD), a life-threatening haemoglobinopathy, into a chronic illness of childhood extending into adulthood. Restrictions in daily life activities, behavioural inhibitions and associated social stigma have led to a significant psycho-socio-economic burden on patients and their families. This study was conducted to estimate the prevalence and severity of psychological comorbidities, namely stress, anxiety and depression among SCD patients and to assess the effect of psychosocial intervention through counselling, patient education and familial and social support. A total of 374 SCD patients aged >12 years, visiting the outpatient department (OPD), were recruited for the study and were assessed for psychological comorbidities using the validated Hindi version of the Depression Anxiety Stress Scale-42 (DASS-42). The questionnaires were administered by a trained psychologist. Out of these, 98 patients who consented for further participation were assessed for the effect of intervention in the form of verbal guidance sessions, self-help group sessions and provision of printed educational material. We observed that 53.74% of 374 patients were affected with at least one of the psychological comorbidities. Stress, anxiety and depression affected 27.54%, 49.20% and 32.89% of patients, respectively. The majority of affected patients had symptoms in the moderate to extremely severe range. We observed that the depression score increased by a factor of 0.419 and 0.558 for anxiety and stress, respectively. Interestingly, we observed a significantly higher prevalence of depression in females ( χ 2 (1) = 8.808, p = .0030). We also observed that prevalence and severity scores for stress, anxiety and depression among the patients showed a significant reduction in response to the psychosocial intervention. Our findings show a higher prevalence of psychological comorbidities in SCD patients and highlight the need for early identification and remediation of psychological comorbidities in SCD patients.

Journal of Health ManagementVol. 27(4)
ITM University (IN), Sickle Cell Institute Chhattisgarh, Raipur (IN), National Eye Institute (US)
Openalex Percentile: Top 80%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.